At a glance
ClinicalIndex Comparison RecordN/ACompleted· 33 enrolled
Drug / intervention
Neurapheresis Systemdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
ExtracorPoreal FILtration of Subarachnoid Hemorrhage Via SpinaL CAtheteR EXTension
In Brief
A clinical study evaluating Neurapheresis System for Subarachnoid Hemorrhage. Completed, enrolled 33 participants across 4 sites.
Detailed Summary
The objective of this study is to further demonstrate safety and characterize effectiveness of the Neurapheresis™ System (extracorporeal system and catheter) to remove red blood cells (RBCs) and lysed blood by-products from hemorrhagic cerebrospinal fluid (CSF) following aneurysmal subarachnoid hemorrhage (aSAH).
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSubarachnoid Hemorrhage
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20192020202120222023202420252026
First PostedJul 2018
Enrollment StartDec 2018
Primary CompletionJan 2021
Study CompletionFeb 2021
TodayJul 2026
First PostedJul 31, 2018
Enrollment StartDec 25, 2018
Primary CompletionJan 11, 2021
Study CompletionFeb 17, 2021
TodayJul 2, 2026
Enrollment to primary: 2.0 yearsPosted 7.9 years ago
Interventions
Neurapheresis Systemdevice
CSF filtration system and lumbar catheter